Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years: A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

IMPORTANCE: The use of prostate-specific antigen (PSA) screening for prostate cancer is controversial because of the risk of overdiagnosis and overtreatment of indolent cancers. Optimal screening strategies are highly sought. OBJECTIVE: To estimate the long-term risk of any prostate cancer and clini...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:JAMA Netw Open
Glavni autori: Kovac, Evan, Carlsson, Sigrid V., Lilja, Hans, Hugosson, Jonas, Kattan, Michael W., Holmberg, Erik, Stephenson, Andrew J.
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2020
Teme:
Original Investigation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6991265/
https://ncbi.nlm.nih.gov/pubmed/31940039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2019.19284
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items